Publication:
Active Surveillance-Factors Affecting the Treatment Decision: 3M: "Marker", "Mapping", "MRI"

dc.contributor.authorOzden, Ender
dc.contributor.authorMercimek, Mehmet Necmettin
dc.contributor.authorIDMercimek, Mehmet Necmettin/0000-0002-0680-4451
dc.date.accessioned2020-06-21T13:46:38Z
dc.date.available2020-06-21T13:46:38Z
dc.date.issued2015
dc.departmentOMÜen_US
dc.department-temp[Ozden, Ender] Ondokuz Mayis Univ, Tip Fak, Urol Anabilim Dali, Samsun, Turkey -- [Mercimek, Mehmet Necmettin] Sanko Univ, Urol Anabilim Dali, Tip Fak, Gaziantep, Turkey --en_US
dc.description.abstractActive Surveillance (AS) is an alternative modality to radical treatment in patients with low-risk prostate cancer. There is a considerable role for AS in carefully selected patients. However the differentiation of clinically important prostate cancer from low risk disease is a major problem. Although more accurate grading was provided with the developments in prostate biopsy techniques, imaging and tumor markers still there is no standard method. This review was aimed to evaluate new developments that might affect the treatment decision in AS patients with prostate cancer.en_US
dc.identifier.doi10.4274/uob.379
dc.identifier.endpage160en_US
dc.identifier.issn2147-2270
dc.identifier.issue2en_US
dc.identifier.startpage156en_US
dc.identifier.urihttps://doi.org/10.4274/uob.379
dc.identifier.urihttps://hdl.handle.net/20.500.12712/14332
dc.identifier.volume14en_US
dc.identifier.wosWOS:000219415700015
dc.language.isotren_US
dc.publisherGalenos Yayinciliken_US
dc.relation.journalUroonkoloji Bulteni-Bulletin of Urooncologyen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectProstate Canceren_US
dc.subjectActive Surveillanceen_US
dc.subjectMagnetic Resonance Imagingen_US
dc.subjectMarkeren_US
dc.titleActive Surveillance-Factors Affecting the Treatment Decision: 3M: "Marker", "Mapping", "MRI"en_US
dc.typeReviewen_US
dspace.entity.typePublication

Files